Efficacy of Hepatitis B Immune Globulin
โ
R. Palmer Beasley; Lu-Yu Hwang; Cladd E. Stevens; Chia-Chin Lin; Fon-Jou Hsieh;
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 603 KB
A randomized double-blind, placebo-controlled efficacy trial of hepatitis B immune globulin (HBIG) for prevention of the mother-to-infant transmitted HBsAg carrier state was conducted in Taiwan where the carrier rate in the general population is 15 to 20%. HBIG was given immediately after birth to i